Azimuth Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $7.42M | Buy |
124,820
+32,944
| +36% | +$2.11M | 0.32% | 120 |
|
|
2021
Q4 | $6.67M | Sell |
91,876
-3,535
| -4% | -$243K | 0.27% | 129 |
|
|
2021
Q3 | $6.66M | Buy |
95,411
+1,336
| +1% | +$93.9K | 0.29% | 128 |
|
|
2021
Q2 | $6.48M | Buy |
94,075
+6,640
| +8% | +$443K | 0.28% | 129 |
|
|
2021
Q1 | $5.65M | Buy |
87,435
+13,635
| +18% | +$879K | 0.27% | 136 |
|
|
2020
Q4 | $4.3M | Buy |
73,800
+32,155
| +77% | +$1.94M | 0.21% | 143 |
|
|
2020
Q3 | $2.63M | Sell |
41,645
-1,525
| -4% | -$106K | 0.15% | 154 |
|
|
2020
Q2 | $3.32M | Buy |
43,170
+1,460
| +4% | +$112K | 0.21% | 127 |
|
|
2020
Q1 | $3.12M | Buy |
41,710
+1,380
| +3% | +$95.4K | 0.23% | 120 |
|
|
2019
Q4 | $2.62M | Sell |
40,330
-455
| -1% | -$29.6K | 0.16% | 163 |
|
|
2019
Q3 | $2.58M | Sell |
40,785
-110
| -0.3% | -$7.19K | 0.17% | 159 |
|
|
2019
Q2 | $2.76M | Sell |
40,895
-100
| -0.2% | -$6.58K | 0.18% | 152 |
|
|
2019
Q1 | $2.67M | Buy |
40,995
+2,100
| +5% | +$140K | 0.18% | 154 |
|
|
2018
Q4 | $2.43M | Buy |
38,895
+545
| +1% | +$38.1K | 0.19% | 148 |
|
|
2018
Q3 | $2.96M | Buy |
38,350
+500
| +1% | +$37.8K | 0.2% | 146 |
|
|
2018
Q2 | $2.68M | Buy |
37,850
+2,417
| +7% | +$171K | 0.19% | 146 |
|
|
2018
Q1 | $2.67M | Sell |
35,433
-404
| -1% | -$32.1K | 0.2% | 151 |
|
|
2017
Q4 | $2.57M | Buy |
35,837
+530
| +2% | +$40.2K | 0.19% | 154 |
|
|
2017
Q3 | $2.86M | Buy |
35,307
+1,700
| +5% | +$130K | 0.21% | 148 |
|
|
2017
Q2 | $2.38M | Buy |
33,607
+1,875
| +6% | +$125K | 0.19% | 153 |
|
|
2017
Q1 | $2.15M | Buy |
31,732
+11,148
| +54% | +$784K | 0.17% | 159 |
|
|
2016
Q4 | $1.47M | Sell |
20,584
-374
| -2% | -$27.8K | 0.13% | 174 |
|
|
2016
Q3 | $1.66M | Buy |
20,958
+3,065
| +17% | +$249K | 0.14% | 164 |
|
|
2016
Q2 | $1.49M | Buy |
17,893
+4,102
| +30% | +$364K | 0.13% | 167 |
|
|
2016
Q1 | $1.27M | Buy |
13,791
+897
| +7% | +$80.9K | 0.12% | 169 |
|
|
2015
Q4 | $1.3M | Buy |
12,894
+8,523
| +195% | +$887K | 0.13% | 169 |
|
|
2015
Q3 | $429K | Buy |
4,371
+150
| +4% | +$16.7K | 0.04% | 235 |
|
|
2015
Q2 | $494K | Sell |
4,221
-52,430
| -93% | -$5.73M | 0.05% | 238 |
|
|
2015
Q1 | $5.56M | Sell |
56,651
-17,010
| -23% | -$1.73M | 0.54% | 62 |
|
|
2014
Q4 | $6.94M | Buy |
73,661
+6,335
| +9% | +$655K | 0.71% | 41 |
|
|
2014
Q3 | $7.17M | Sell |
67,326
-9,508
| -12% | -$931K | 0.79% | 37 |
|
|
2014
Q2 | $6.37M | Sell |
76,834
-9,017
| -11% | -$702K | 0.71% | 42 |
|
|
2014
Q1 | $6.08M | Buy |
85,851
+27,121
| +46% | +$2.13M | 0.73% | 41 |
|
|
2013
Q4 | $4.41M | Buy |
58,730
+1,825
| +3% | +$127K | 0.53% | 70 |
|
|
2013
Q3 | $3.58M | Buy |
+56,905
| New | +$3.4M | 0.49% | 74 |
|
Other funds holding GILD
Azimuth Capital Management's GILD Position: Q1 2022 in Review
Azimuth Capital Management increased its Gilead Sciences (GILD) stake by 36% in Q1 2022, buying an estimated $2.11M and bringing the position to 124,820 shares worth $7.42M. The position accounts for 0.32% of the portfolio, ranked #120.
Azimuth Capital Management first reported a position in GILD in Q3 2013 and has held it in 35 quarters since. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Azimuth Capital Management held 124,820 shares of Gilead Sciences worth $7.42M as of Q1 2022.
- Azimuth Capital Management bought 32,944 Gilead Sciences shares in Q1 2022, an estimated $2.11M.
- Gilead Sciences made up 0.32% of Azimuth Capital Management's portfolio in Q1 2022, its #120 holding.
- Azimuth Capital Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 35 quarters since.
- 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.